A new treatment which could prolong the lives of lung cancer patients is to be trialled nationally. About 38,000 people are diagnosed with inoperable lung cancer in the UK every year and normal life expectancy for patients is about eight months. Tests in Liverpool showed a new combined treatment extended patients’ lives by between one and five years. Doctors gave 75 patients high doses of chemoradiation and radical radiotherapy between 1997 and 2004. The research was carried out at the Liverpool Lung Cancer Unit and the results revealed at a meeting of the British Thoracic Society in London.
